Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 22, 2007. The document serves as a notice of the company's Annual General Meeting (AGM) scheduled for May 23, 2007, and announces the availability of the 2006 Annual Report and 2006 Annual Review.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding corporate governance and document availability rather than a financial results report.
Material Changes
No material financial changes or operational updates are detailed in this specific filing. The primary update is the scheduling of the AGM and the release of the 2006 annual documentation.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly outlines the logistics for the AGM and the locations where the 2006 Annual Report can be inspected.
Investor Verification Checklist
- Verify the date and location of the Annual General Meeting (May 23, 2007, London).
- Access the 2006 Annual Report and 2006 Annual Review via the company website (www.gsk.com) or the UK Listing Authority's Document Viewing Facility for detailed financial data.
- Confirm the submission of these documents to the UK Listing Authority as stated in the notice.